Embed from Getty Images
I interview friends, colleagues, and experts, on harm reduction and its implications in Canadian society, from the theory to the practice, to the practical. I am a Member-at-Large for Outreach for Canadian Students for Sensible Drug Policy and writer for Karmik, Fresh Start Recovery Centre, and the Marijuana Party of Canada. Here I interview Gonzo Nieto, part 1.
Scott Douglas Jacobsen: How did you become interested in being involved in drug policy in Canada?
Gonzo Nieto:My interest with drug policy began with my own use, which started with cannabis as a teen. A lot of my peers were using drugs, both in high school and university. That all began to get me interested in the phenomenon of drug use in general.
What really caught my interest was psychedelics, after I had my first experience with psilocybin mushrooms. I began to educate myself pretty extensively about psychedelics. I would spend hours listening to lectures and talks by various people, reading books, and browsing forums and seeing what was there in terms of other peoples experiences.
This got the ball rolling as I began to discover how large and diverse the field of drug policy is, and I fell further and further down the rabbit hole.
Jacobsen: With respect to personal use, how much knowledge did you have beforehand about medical and psychological effects?
Nieto:Not very much, I didnt come into drug use in a very informed way. It was youthful curiosity and blissful ignorance that led me to try cannabis and psilocybin mushrooms. These experiences stoked my curiosity, and then I got to educating myself more. When I started smoking pot, I didnt know much other than that my friends were using it.
When some of my peers were using psychedelics in high school, I mostly recall hearing myths and lies about psychedelics. I remember hearing kids at school say that magic mushrooms make your brain bleed, and thats why you hallucinate. Silly stuff like that. I remember others saying it was a fun trip, describing psychedelics like the next level up from pot, which I came to learn is not the case theyre completely different.
But like most people, I wasnt very well educated about drugs prior to encountering and trying them. I didnt have good drug education at my school, at least good by my standards what we got was police officers come to our school to scare us about the scourge of drugs.
Jacobsen: How did you get involved with Canadian Students for Sensible Drug Policy?
Nieto:After I graduated university, my partner motivated me to start writing a column on drugs using the knowledge I had amassed during the previous five years of my undergrad. I began writing a column in the student newspaper, which I calledTurning Inward.
The column went really well. Pretty much every time I published an article, it became one of the most read articles in the student newspaper for that week. I continued writing articles regularly for about seven months.
One of the articles that I wrote was calledMDMA: A Guide to Harm Reduction. I wrote it because several friends that previous week had asked me questions about MDMA that, to me, were fairly basic because of what I had been learning and reading about. I realized this sort of stuff wasnt common knowledge for most of my peers.
CSSDP shared my article on Twitter. I contacted CSSDP to thank them for sharing it and to ask how I could get involved. They responded that I should try to attend their conference coming up in Toronto. At the conference, they were electing new members to the organizations board, so I decided to put my name in the hat.
Jacobsen: What do you consider the core principle of CSSDP?
Nieto:Primarily, I would say the core value is the idea that drug use should not be treated as a criminal justice issue, but rather as an issue of public health and social cohesion.
Jacobsen: Two philosophies compete with regards to how to deal with issues like youth drug use, the zero tolerance approach, and the harm reduction model. Which do you prefer, and why?
Nieto:I stand by the harm reduction model, without question. In the debates around drug use, these two models are sometimes presented as though they are equally valid in some sense, but I think theres a strong case to be made that the punitive approach is in denial of reality.
That perspective is based on the assumption that some set of actions could be taken which would result in total abstinence across the board. Thats just not true, as demonstrated by the decades that precede us.
Drug use appears to be a core component of the human species. To say that human drug use dates back tens of thousands of years is probably a conservative estimate. Any recorded history of humans shows humans using drugs. Its not a new phenomenon. What is relatively new is outlawing and punishing drug use, and theres an argument to be made that the punishments in place for drug crimes cause far more damage to the individual and society than the use of drugs does in the first place.
The harm reduction model recognizes that, no matter how refined the attempts at prevention may be, some people will still choose to use drugs, and there needs to be education and services in place that help reduce the preventable harms associated with that drug use.Harm reduction meets people where they are rather than telling them what they should or should not do. It says, If you do use, heres some information and services to ensure your safety and to help minimize preventable harms.
Harm reduction meets people where they are rather than telling them what they should or should not do. It says, If you do use, heres some information and services to ensure your safety and to help minimize preventable harms.
Original publication on http://www.cssdp.org.
Photo Credit: Getty Images
Scott Douglas Jacobsen founded In-Sight Publishing and In-Sight: Independent Interview-Based Journal. He works as an Associate Editor and Contributor for Conatus News, Editor and Contributor to The Good Men Project, a Board Member, Executive International Committee (International Research and Project Management) Member, and as the Chair of Social Media for the Almas Jiwani Foundation, Executive Administrator and Writer for Trusted Clothes, and Councillor in the Athabasca University Students Union. He contributes to the Basic Income Earth Network, The Beam, Canadian Students for Sensible Drug Policy, Check Your Head, Conatus News, Humanist Voices, The Voice Magazine, and Trusted Clothes. If you want to contact Scott: [emailprotected]; website: http://www.in-sightjournal.com; Twitter: https://twitter.com/InSight_Journal.
Go here to read the rest:
- Are NDEs caused by carbon dioxide overload? And what about psychedelics? - Patheos - June 24th, 2020
- ATAI dives into digital therapeutics to boost mental health care - FierceBiotech - June 24th, 2020
- 'People Should Have the Fundamental Right To Change Their Consciousness' - Reason - June 24th, 2020
- Revive Therapeutics betting on psychedelics and potential COVID-19 treatment Bucillamine - Proactive Investors USA & Canada - June 20th, 2020
- These Psychedelic Drugs May Be Key to Revolutionizing Weight Loss Treatment - Yahoo Finance - June 20th, 2020
- Champignon Brands CEO Dr Roger McIntyre authors studies appearing in two leading scientific journals - Proactive Investors USA & Canada - June 20th, 2020
- The effects of psychedelics on the brain's "consciousness conductor" - New Atlas - June 17th, 2020
- Psilocybin Dulls Activity in Brain Region Linked With Consciousness - Psych Congress Network - June 17th, 2020
- Champignon Brands revamps its brand identity to better reflect its scientific focus on psychedelic medicine - Proactive Investors UK - June 17th, 2020
- Mota Ventures Appoints Roger C. Clinton as Member of Advisory Board to Verrian GmbH - Its Psilocybin Research Subsidiary - Stockhouse - June 17th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week - Yahoo Finance - June 13th, 2020
- New Psychedelics Stocks and Acquisitions | 2020-06-08 | Investing News - Stockhouse - June 13th, 2020
- Pure Extracts: The Second Wave of Psychedelic Operators - The Deep Dive - June 13th, 2020
- New analysis claims the FDA rushed ketamine's approval for depression treatment - Big Think - June 13th, 2020
- How Liv Vasquez Uses Plants & Food for Wellness and Healing - Thrillist - June 13th, 2020
- Companies are starting to bet big on psychedelic drugs to treat US mental health epidemic - Proactive Investors USA & Canada - June 6th, 2020
- CHECK IT OUT: New from Lady Gaga; take a wild ride; beach reading; and a screen gem - Wicked Local - June 6th, 2020
- Dr. Bronner's Soaps Wants to Protect You From COVIDand Legalize Your Right to Magic Mushrooms - Mother Jones - June 6th, 2020
- 6 celebrities wildest psychedelic trips, as told by themselves - Insider - INSIDER - June 1st, 2020
- Rate and Review: Have a Good Trip - The Independent Florida Alligator - June 1st, 2020
- First-of-Its-Kind Study Hints at How Psilocybin Works in The Brain to Dissolve Ego - ScienceAlert - June 1st, 2020
- Codebase says psychedelic investee Red Light Holland debuts on CSE with ticker TRIP - Proactive Investors USA & Canada - June 1st, 2020
- Todd Shapiro of Red Light Holland on 'magic truffles' and the multi-billion dollar psychedelics market - InvestorIntel - June 1st, 2020
- This Trippy Oregon Theme Park Is A Low-Key Psychedelic Playground - Thrillist - May 15th, 2020
- EGF Theramed Appoints George Anstey to Board of Directors - Benzinga - May 15th, 2020
- Empower Clinics and EuroLife Brands Close Definitive Agreement and Sign Multi-Year Multi-National Licence Agreement - GuruFocus.com - May 15th, 2020
- Have a Good Trip Demystifies Psychedelics - The New Republic - May 14th, 2020
- Investing in Psychedelics - Energy and Capital - May 14th, 2020
- Psilocybin May be the Key to Treating a Range of Health Issues, Including Obesity - Baystreet.ca - May 14th, 2020
- Movie review: Netflix's 'Have a Good Trip' is only a mild high - Eagle-Tribune - May 14th, 2020
- Psychedelics - Alcohol and Drug Foundation - May 10th, 2020
- Celebrities share LSD trips in Netflix documentary 'Have A Good Trip' - Insider - INSIDER - May 10th, 2020
- The Queen of Consciousness Driving Psychedelic Study and Advocacy - Filter - May 10th, 2020
- The 'Billions' Stock Watch: It's Time For Psychedelics And Subterfuge - UPROXX - May 10th, 2020
- Have a Good Trip: Netflix release and cast as celebrities recall mind-bending experiences - Mirror Online - May 10th, 2020
- From "Solar Opposites" to "Midnight Gospel," recent otherworldly animation is worth the head-trip - Salon - May 10th, 2020
- Netflix Reveals Celebrities' Wildest Drug Trips, From Anthony Bourdain to Carrie Fisher - The Daily Beast - May 10th, 2020
- Psychedelic mushrooms for depression: 'This is the one that changed things' - DW (English) - April 26th, 2020
- MindMed wants to develop a drug to help end a bad LSD trip - Fast Company - April 26th, 2020
- Netflixs The Midnight Gospel Is a Profoundly Weird Psychedelic Trip You Want To Take - Mashable India - April 26th, 2020
- Professor describes uses and history of hallucinogens - The Daily Evergreen - April 26th, 2020
- Media Central moves to provide coverage on emerging Psychedelics and eGames sectors - Proactive Investors USA & Canada - April 26th, 2020
- This video game does the same things to your brain as magic mushrooms - Happy Mag - April 26th, 2020
- Inborn Psychedelia on White Nights' Into the Lap of the Ancient Mother - Invisible Oranges - April 26th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Yahoo Finance - April 9th, 2020
- Psychedelic mushrooms could affect the brain long after its active ingredient leaves the system - The Next Web - April 9th, 2020
- We Could Be Taking Psychedelics to Help Treat Mental Illness in Just Five Years - Newsweek - April 7th, 2020
- Magic mushrooms to treat depression? COMPASS Pathways pushes forward with U.S. patent for psilocybin therapy - Straight.com - April 7th, 2020
- Key Insights from PSYCH: The Psychedelics as Medicine Report - Prohibition Partners - March 18th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Benzinga - March 18th, 2020
- With No Progress in Therapy, NYC Couple Turns to Psychedelics for Help - NBC New York - March 13th, 2020
- Upscale Psychedelics Therapy Center Opens On New Yorks 5th Avenue - Forbes - March 13th, 2020
- Why Kevin O'Leary is betting on psychedelics - Wealth Professional - March 13th, 2020
- Learning the hard way that psychedelic drug use can have long-term consequences - Dailyuw - March 13th, 2020
- Forget taking a pill a day. Canada is using psychedelics to revolutionize the way we treat mental health and addiction - The GrowthOp - March 13th, 2020
- High Stakes: Will The Legalization Of Psychedelics Mimic That Of Cannabis? Will It Learn From Its Mistakes? - Benzinga - March 13th, 2020
- Scientists Just Proved These Two Brain Networks Are Key to Consciousness - Singularity Hub - March 13th, 2020
- Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week - MarketWatch - March 13th, 2020
- Podcast Host Joe Rogan Is Steadily Documenting A Psychedelic Record Of The 21st Century - Forbes - February 27th, 2020
- Empower Clinics to create psilocybin and psychadelics division leveraging corporate wellness and franchise clinic network - Proactive Investors USA... - February 27th, 2020
- The Psilocybin Movement Is Like The Cannabis Movement (Except When It's Not) - Benzinga - February 27th, 2020
- Researchers went to festivals to study psychedelic drugs and found they left people feeling happy and connected hours after the high wore off -... - January 22nd, 2020
- Psychedelics and Their 'Mystical Effects' in the Real World - Medscape - January 22nd, 2020
- Psychedelic Events Are Going Mainstream, Where The Much-Maligned Mushroom Industry Focuses On Mental Health - Forbes - January 18th, 2020
- Psychedelics have 'extraordinarily potent' anti-inflammatory power. Is there a place for them in mainstream medicine? - Genetic Literacy Project - January 18th, 2020
- Silicon Valley Is Micro-Dosing Magic Mushrooms To Boost Their Careers - Forbes - January 18th, 2020
- NYC To Host Economics Of Psychedelics Investing Summit - Benzinga - January 18th, 2020
- The Best FREE Things to Do for the Next Week - My New Orleans - January 18th, 2020
- Photos of the Stuff That Fascinates People While They're Tripping On LSD - VICE - January 18th, 2020
- Rats on DMT hint at the benefits of psychedelic microdosing - Inverse - December 31st, 2019
- BEYOND LOCAL: Would you ever consider psychedelics to treat PTSD? - SooToday.com - December 31st, 2019
- A Trailblazer of Global Consciousness: Ram Dass Led the Way - Psychology Today - December 31st, 2019
- The Psychedelic Renaissance and the importance of drug policy reform - Open Access Government - December 13th, 2019
- Magic Mushrooms Move Closer to Mainstream Medicine As VC-Backed Compass Touts Safety, Positive Mood Alteration - Karma - December 13th, 2019
- Miami Clinics Use Ketamine IV Therapy to Help Treat Depression and PTSD - Miami New Times - December 13th, 2019
- Andy Frasco Talks Finding Emotional Balance With Psychedelics On 'Psychedelics Today' Podcast [Listen] - Live for Live Music - November 30th, 2019
- Will psychedelics be available commonly in the near future? - BPhrm Dv - November 30th, 2019
- Letters to the Editor: Psychedelics on their way - Valley Advocate - November 30th, 2019
- Scientists Have a Fascinating New Map of the Human Brain on DMT - VICE - November 30th, 2019
- Hes a fungi: U.S. health agency asks researcher to give it the lowdown on psilocybin mushrooms - The GrowthOp - November 30th, 2019